Biotechnology in Taiwan

Ever Supreme Bio Technology Co., Ltd. 6712.Two

Ever Supreme Bio Technology is a clinical-stage biotech company focused on developing next-generation allogeneic cell therapies for solid tumors. Its lead candidate, CAR001, combines gamma delta T cells targeting HLA-G with BiTE-mediated PD-L1 engagement to overcome two major barriers in current solid tumor treatment: tumor heterogeneity and immune evasion. With operations in Taiwan and early clinical trials underway, Ever Supreme also runs a revenue-generating CDMO platform and is expanding its pipeline to include stem cell and exosome-based therapies. Backed by a strong IP portfolio across seven countries and deep clinical expertise, the company is strategically positioned to deliver scalable, off-the-shelf immunotherapies that are safe, effective, and globally accessible.

51 to 200 staff

Field Cycling Technology Ltd

We are a team eager to meet the challenges of NMR-related technologies. Our objective is to develop and provide innovative scientific instruments for nuclear magnetic resonance (NMR) research. Nowadays, we specialize in unique instrumentation for High-Resolution Field-Cycling NMR Relaxometry and focus on the continuous development of this technology and the diversity of the Field-Cycling NMR method for academic and industrial purposes. Our high-quality design and manufacture permitted our products to implement for several types of research in the following collaboration partners. We are also actively involved in versatile NMR research.

1 to 10 staff

Mithra Biotechnology Inc

Mithra Biotechnology Inc. is the first Contract Research Organization (CRO) in Taiwan since 1988. We offer integrated and multi-dimensional CRO services, including bioanalytical services for chemical drugs and biologics, full characterization plans for biologics, bioavailability/bioequivalence (BA/BE) studies, and phase I to IV clinical trials to facilitate pharmaceutical development. Mithra possesses expertise and experience in meeting international standards to serve the fast-growing pharmaceutical industry. We are committed to each project from the very beginning to its completion. It is our goal to exceed clients’ expectations and help achieve your long-term goals.

51 to 200 staff

Play&joy Innovemed Bio-Tech Co., Ltd

The base of natural herbal health materials makes women feel better. The thought design of gender equality is not only the satisfaction of men, but also the pleasure of women.

11 to 50 staff

Revlis Biotech Company Limited

Our mission is to bring health management to individuals. We aim to position ourselves as a leading healthcare company by leveraging non-invasive technology, artificial intelligence algorithm, and big data processing for personalized service. Founded in 2003, Revlis Biotech Company Ltd. embarked on the development of health and medical products. Cmate, a portable Gen I ECG and the company’s first commercial medical product, has obtained medical grade certification necessary for our launch in 2012. The scalability of our technology and service platform has enabled us to expand our product road-map from fully medical to health & wellness solutions.

51 to 200 staff

Giant Bio Technology Inc

Giant Bio Technology Inc. is a startup company derived from National Taiwan Ocean University, Taiwan. We own a patented technology platform for antibiotic alternatives – Herbmedotcin. Herbmedotcin – a molecular herbal technology that is scientific, provides safer and more effective materials to replace antibiotics, nanometals and chemical preservatives, especially in livestock feed and health care product industries. Use “Herbmedotcin” to produce products, substitute antibiotics, and achieve the goal of natural, non-toxic and effective control of microorganisms. We are open to make business partners both B to B and B to C at national and international level.

1 to 10 staff

Libo Pharma Corp

About Libo Pharma Founded in 2017, Libo Pharma Corp. is dedicated to developing innovative therapies that address significant unmet medical needs. Our lead asset, NM-IL-12, is a first-in-class cytokine-based immunomodulator with multiple mechanisms of action, including immune regulation, hematopoiesis enhancement, radiation damage mitigation, and anti-tumor activity. Our Lead Product: NM-IL-12 NM-IL-12 has received orphan drug designation from both the U.S. FDA and European Medicines Agency (EMA) for the treatment of cutaneous T-cell lymphoma (CTCL) and is advancing into a Phase 3 clinical trial, with strong potential for regulatory approval and commercialization. The product has also completed Phase 2 clinical trials for Hematopoietic Syndrome of Acute Radiation Syndrome(HSARS) and open wound healing, and is currently expanded into new indications including diffuse large B-cell lymphoma (DLBCL) and other solid tumors—highlighting a robust and diversified pipeline. Innovation & Capabilities Libo Pharma maintains a globally competitive intellectual property portfolio, covering key markets such as the United States, Europe, and Japan. We retain full control over the manufacturing processes and biological materials related to NM-IL-12, ensuring a high level of autonomy across product development and production. Backed by a highly experienced scientific and regulatory team, we are well-positioned to drive forward our development programs from clinical validation to commercial launch. Clinical Experience To date, NM-IL-12 has been administered in over 200 human subjects, consistently demonstrating a favorable safety and efficacy profile. Its ability to be used in combination with standard therapies including chemotherapy, radiotherapy, and immune checkpoint inhibitors offers promising opportunities to enhance treatment outcomes across multiple cancer types.

11 to 50 staff

Medigen Biotechnology Corp 3176

Medigen Biotechnology Corp (3176) is a biotechnology company based out of Yuanqu Street, Nangang District, Taipei, Taiwan.

11 to 50 staff

Pacific Deep Ocean Biotech Ltd

Pacific Deep Ocean Biotech Co, Ltd.(PDOB) was formed to pioneer the potential applications of the rich pure source of minerals and trace elements in Deep Ocean Water. We source deep ocean water from a depth of over 600 meters near Taitung and Hualien on the east coast of Taiwan. This is a beautiful region with rugged steep mountains running down to the coast line. Over the last 15 years, the Taiwanese Government has generously sponsored research and development to improve the technologies to access deep ocean water and to concentrate the minerals and trace elements. Additionally, they have sponsored clinical, agricultural, and fisheries trials to establish the merits of deep ocean water. PDOB's mission is to commercialize the many beneficial applications using the deep ocean water. We will continue to undertake research and focus on the potential and exciting biotech applications. We aim to also expand and create employment opportunities that relate to the ocean and the history of the region. The manufacturing facilities already incorporate green technologies and environmental policies to compliment the beautiful landscape. We are seeking to establish partnerships with other innovative companies best in the industry to collaborate and utilizing our unique technologies and experience.

11 to 50 staff

Syneurx International Taiwan Corp

Mission The mission of SyneuRx is to use a humanistic approach to bring breakthrough therapeutics to diseases and conditions where there are significant unmet needs. Antiviral Platform - Antiviral for COVID-19 Currently, SyneuRx is conducting two clinical programs of COVID-19 treatments— Pentarlandir® as an oral capsule and Airnecflu® as an inhaled treatment. The company’s COVID-19 efforts began in February 2020 as COVID-19 emerged to be a global pandemic, SyneuRx decided to apply its extensive R&D experience with CNS therapeutics toward R&D for COVID-19 antivirals in an effort to help develop a safe, effective, and accessible treatment that would prevent the progression and transmission of the disease. SyneuRx scientists arrived at the theory that regulatory enzymes such as protease would be a critically-important ‘drug target’ for these types of illnesses, which coincidentally is also a target for several virally-caused diseases such as HIV and hepatitis. Researchers decided to test the company’s proprietary library of compounds against the protease and discovered that the compound that became Pentarlandir proved to be the most safe and efficacious in preclinical tests. Pentarlandir’s ability to block coronavirus replication was confirmed in multiple, rigorous cellular studies and it was also proved to maintain an excellent safety profile, which made Pentarlandir an ideal candidate to go into clinical development. NMDA Platform - Modulation For CNS Disorders A New Perspective on Brain Function Modulation SyneuRx believes that NMDA receptors are the grand regulator of the brain. Therefore, solutions to the current unmet needs in many central nervous system (CNS) disorders need to involve therapies that modulate NMDA receptor functions.

11 to 50 staff

Atp-Bio Co., Ltd

Health and Beauty We Create for the World Private label and contract manufacturing of health and beauty food, drink, and cosmetics. We efficiently supply good-quality products and services.

51 to 200 staff

Taiwan User-Friendly Sensor & Tech

We are Taiwan User-Friendly Sensor & Tech focusing on food safety issues, especially for food allergy."Test Food Allergen Detection System (TADs)" consists of a test channel, a portable device, and an app system. With the feature of high sensitivity, the device can provide accurate and detailed data about foods in 2 minutes that can help people know more about the allergen contained in foods they are going to eat. We believe that people will get a safer diet in a simple way by using TADs.

1 to 10 staff

What's Up Tech

What’s Up is a biotech company that uses artificial intelligence, 5G technology, and big data analysis to effectively find cost-efficient methods and risk-averse solutions to treat medical impairments. Our product allows manufacturers to effortlessly understand the necessary solution so that each step of the supply chain is faster and smoother. The satisfaction and the livelihood of our customers is our highest priority.

1 to 10 staff

Mithra Biotechnology Inc

Mithra Biotechnology Inc. is the first Contract Research Organization (CRO) in Taiwan since 1988. We offer integrated and multi-dimensional CRO services, including bioanalytical services for chemical drugs and biologics, full characterization plans for biologics, bioavailability/bioequivalence (BA/BE) studies, and phase I to IV clinical trials to facilitate pharmaceutical development. Mithra possesses expertise and experience in meeting international standards to serve the fast-growing pharmaceutical industry. We are committed to each project from the very beginning to its completion. It is our goal to exceed clients’ expectations and help achieve your long-term goals.

51 to 200 staff

Retain Biotech

Retain Biotech is the first joint venture of National Taiwan University and YongLin Healthcare Foundation, incorporating tripartite resources from industry, academia and research sectors. We integrate the research strength from National Taiwan University, years of extensive clinical experience in the field of stem cell therapy from Tai Chen Cell Therapy Center and vast resources put into the fields of preventive medicine and cancer therapy by YongLin Healthcare Foundation. From the perspective of preventive medicine, Retain Biotech achieves personalized healthcare management with the preservation of stem cells or immune cells at the early stage and high-end healthcare management. By integrating big data analysis, the most appropriate disease management will be provided by our service. When disease occur, we can maximize and optimize the application of medical resources.

11 to 50 staff

Level Biotechnology Inc

Level Biotechnology Inc. was founded in 1989. This company was originally set up for marketing and distributing cell culture,immunology, molecular biology products and biomedical precision equipments.We decided to establish CRO for preclinical services for NEC (New entity chemicals), medical device and other related products in Level Biotechnology Inc. is widely recognized as one of the top biotech companies offering excellent products and best preclinical CRO services in Taiwan. With great customer-oriented services, knowledgeable sales representatives, efficient logistics operations,good management experience and well-balanced financial schemes, Level Biotechnology Inc.has already established an excellent reputation and good relationship with customers around the world. We are certificated for consistent service quality by the Our CRO services cover more than 9,900 square yards of laboratory space. The animal facility has been accredited by International since 2007. All areas of the facility are designed and built for comfortable environment for modern contract research studies. All tests conducted are audited by an independent Quality Assurance Unit (QAU) and complied with Good Laboratory Practice(GLP). In addition, more than thirty testing items have been accredited by Taiwan Accreditation Foundation(TAF) in compliance with guide ISO 17025.

51 to 200 staff

National Health Research Institutes

201 to 500 staff

Mektec Corporation

1 to 10 staff

Cheng Ching Hospital

11 to 50 staff

Eps Bio Technology Corp 4183

麗彤生醫科技股份有限公司

501 to 1000 staff

Lumistar Biotechnology, Inc. 昱星生物科技

LumiSTAR is developing a pipeline of innovative cell therapies based on induced pluripotent stem cell (iPSC) technology. These therapies have the potential to revolutionize the treatment of a wide range of diseases, including neurodegenerative diseases such as Parkinson’s and Alzheimer’s, kidney failure and cancer. Other than cell therapy, the company also equipped with iPSC and bioimaging-based high throughput drug screening platform to develop new drugs. The platform uses iPSC to create disease models for drug discovery and screening, allowing for more accurate and efficient identification of potential drug candidates.

11 to 50 staff

Le Biomedical Corp. Lebm 昇級生醫 股

LE Biomedical Corp.(LEBM) is a Taiwan-based AI healthtech company building next-generation infrastructure for pharmacy operations, healthcare innovation, and AI-enabled biomedical solutions. Our flagship platform, PharmaDemand AI, is an AI-native demand forecasting and replenishment optimization solution purpose-built for pharmacies. It combines historical POS data, inventory signals, and Consumer Digital Twin intelligence to generate probabilistic 7 / 30 / 90-day SKU-level demand forecasts and smarter reorder recommendations. We focus on one of the hardest problems in pharmacy retail: • reducing stockout risk • lowering expiry-related waste • improving inventory turnover • supporting better store-level inventory decisions Unlike generic retail AI, our approach is designed for pharmacy-specific complexity, including long-tail SKUs, substitution effects, censored demand from stockouts, and expiry constraints. In 2026, LEBM introduced PharmaDemand AI at SusHi Tech Tokyo 2026 as part of the Taiwan startup delegation. We are expanding from Taiwan into Japan and actively seeking pharmacy chain partners, strategic investors, and technology collaborators for pilot projects and market deployment based in Taipei and Tokyo.

11 to 50 staff

創生醫電 Plasmonictron

Welcome to page of Tron, we are a start-up company that focus on enabling Plasmonic technology.

1 to 10 staff